The Chemtrade/Canexus Deal: Issues, Challenges and Strategy Under the New Takeover Rules


April 26, 2017


8:00 AM - 9:30 AM


Toronto, Ontario

Delivery Method

In Person


Chemtrade’s unsolicited offer for Canexus was the first hostile bid for a TSX-listed issuer under the new takeover bid regime. While a friendly deal was ultimately reached, the transaction had a number of interesting features, including public bear hug letters, shareholder pressure on the Canexus board and a requisitioned meeting by one of Canexus' largest shareholders.

Join us at the Osler Conference Centre on Wednesday April 26th for a candid discussion where members from both teams will discuss;

  • The “why”, “when”, & “how” of the transaction;
  • Key events that motivated the deal; and
  • How the new regime impacted the decisions.


  • Arthur Korpach, Director, Canexus
  • Mark Davis, President and Chief Executive Officer, Chemtrade
  • Jeremy Fraiberg, Partner, Osler
  • Keith Chatwin, Partner, Stikeman Elliott


  • Amy Freedman, Chief Executive Officer, Kingsdale Advisors

Registration Info

Register Online.

CLE/CPD Credit Information

Ontario – Substantive - 1.25


Jeremy Fraiberg

Partner, Corporate